Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-24-044300
Filing Date
2024-10-30
Accepted
2024-10-30 16:03:09
Documents
4
Effectiveness Date
2024-10-30

Document Format Files

Seq Description Document Type Size
1 S-8 csbrs-8_2021equityplanregi.htm S-8 217618
2 EX-FILING FEES csbrs-8_ex107xfilingfeetab.htm EX-FILING FEES 19878
3 EX-5.1 csbrs-8_ex51xopinionofelle.htm EX-5.1 14389
4 EX-23.1 csbrs-8_ex231xeisneramperc.htm EX-23.1 3034
  Complete submission text file 0001628280-24-044300.txt   256304
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: S-8 | Act: 33 | File No.: 333-282896 | Film No.: 241410220
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)